Evaluation of the Completeness and Timeliness of the Infant Pertussis Surveillance System in the Czech Republic in 2015, 2017 and 2019

ABSTRACT Introduction The completeness and timeliness of the pertussis questionnaire-based enhanced surveillance system (ESS) among infants and reported pertussis data within the electronic nationwide notification system (NNS) in the years 2015, 2017 and 2019 were evaluated in a pilot study. Methods The completeness of the variables for demographic characteristics, date of symptom onset, hospitalisation and vaccination status were assessed in both systems. Timeliness of reporting in the NNS was analysed as the interval between symptom onset and a) the date of first specimen collection (diagnostic delay), and b) the date of the Regional Public Health Authority receiving notification (notification delay). Results A total of 121 confirmed pertussis cases were reported to the NNS in the study years, while in the ESS a total of 104 confirmed cases were reported in infants. In both systems most cases were in the age group of one completed month of life (20% versus 23%) and males (55% versus 55%). The majority of cases were hospitalised (81% versus 85%) and unvaccinated (77% versus 78%). Within the NNS, the first dose of vaccine was reported in 13 cases, the second dose in 11, and third dose in three cases. Within the NNS, 100% completeness of following variables was found: symptom onset, week and region of reporting, age, gender and place of isolation. Median diagnostic delay was nine days. Median notification delay was 18 days. Conclusions Data completeness was high in the NNS, except for lack of vaccination data in those eligible by age. Efforts to improve the completeness of laboratory-related variables and timeliness are essential. Based on the study results, the project of improving the ESS for infants will continue with regular evaluation.

[1]  M. Valenciano,et al.  Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother's vaccination in pregnancy in infants aged 2-11 months , 2022, Vaccine.

[2]  C. Rizzo,et al.  The impact of pertussis in infants: insights from a hospital-based enhanced surveillance system, Lazio region, Italy, 2016 to 2019 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  M. Valenciano,et al.  Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018. , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[4]  A. Mattei,et al.  Pertussis in Italy: how to protect the “unprotectable”? , 2020, Human vaccines & immunotherapeutics.

[5]  A. Guignard,et al.  A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis , 2020, Expert review of vaccines.

[6]  A. Nitsch-Osuch,et al.  Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013 , 2016, PloS one.

[7]  P. Krizova,et al.  The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation , 2015, PloS one.

[8]  L. Nilsson,et al.  Surveillance of infant pertussis in Sweden 1998-2012; severity of disease in relation to the national vaccination programme. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[9]  B. Kříž,et al.  [Pertussis trend in children under one year of age in the Czech Republic in 1997-2013]. , 2014, Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne.

[10]  M. Rosińska,et al.  Cross-border surveillance differences: tick-borne encephalitis and lyme borreliosis in the Czech Republic and Poland, 1999-2008. , 2014, Central European journal of public health.

[11]  Jim E van Steenbergen,et al.  Analysis of timeliness of infectious disease reporting in the Netherlands , 2011, BMC public health.

[12]  J. Kovář,et al.  CYP7A1 promoter polymorphism −203A>C affects bile salt synthesis rate in patients after ileal resection Published, JLR Papers in Press, August 26, 2008. This work was supported by Grant NR 8963-3 from the Ministry of Health of the Czech Republic. , 2008, Journal of Lipid Research.

[13]  P. Kriz Surveillance of invasive meningococcal disease in the Czech Republic. , 2004, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[14]  J. Kynčl,et al.  What risk factors affect hospitalisation for confirmed pertussis cases among infants in the Czech Republic? , 2022, Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne.

[15]  R. Evans European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[16]  Shane Marley,et al.  Control of Communicable Diseases Manual , 1997, Annals of Internal Medicine.

[17]  S. Miller,et al.  Control of communicable diseases. , 1949, The Journal-lancet.